TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Life Genomics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,974
|
45,802
|
122,811 |
Financial expenses |
1
|
88
|
0 |
Earnings before taxes |
-5,169
|
-30,303
|
53,586 |
EBITDA |
-4,936
|
-24,620
|
56,508 |
Total assets |
25,872
|
43,356
|
68,677 |
Current assets |
24,656
|
41,707
|
45,798 |
Current liabilities |
5,339
|
17,655
|
14,230 |
Equity capital |
20,533
|
25,701
|
51,563 |
- share capital |
451
![]() |
451
![]() |
451 |
Employees (average) |
10
|
18
|
23 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
79.4%
|
59.3%
|
75.1% |
Turnover per employee |
2,997
|
2,545
|
5,340 |
Profit as a percentage of turnover |
-17.2%
|
-66.2%
|
43.6% |
Return on assets (ROA) |
-20.0%
|
-69.7%
|
78.0% |
Current ratio |
461.8%
|
236.2%
|
321.8% |
Return on equity (ROE) |
-25.2%
|
-117.9%
|
103.9% |
Change turnover |
-15,828
|
-77,009
|
99,548 |
Change turnover % |
-35%
|
-63%
|
428% |
Chg. No. of employees |
-8
|
-5
|
17 |
Chg. No. of employees % |
-44%
|
-22%
|
283% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.